GlassScriptPhysician profile
Timothy R Moore
NPI 1124064423
$2,866.62
in general payments reported to CMS, 2019-2025
20 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,176 · 2020: $122 · 2021: $944 · 2022: $262 · 2023: $83.75 · 2024: $179 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $562.85 | 2019-2022 | |
| Abbott Laboratories | $461.42 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $289.92 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $285.63 | 2022-2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $215.57 | 2019-2022 | |
| Biotronik INC. | $161.04 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $133.63 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $116.24 | 2021 | |
| Esperion Therapeutics, INC. | $112.59 | 2021 | |
| Atricure, INC. | $98.38 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $88.04 | 2019 | |
| Pfizer INC. | $72.92 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $71.96 | 2019 | |
| Irhythm Technologies, INC. | $67.35 | 2021 | |
| Medtronic Vascular, INC. | $55.16 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $24.00 | 2021 | |
| Amgen INC. | $14.33 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.20 | 2021 | |
| Preventice Services, LLC | $12.17 | 2021 | |
| United Therapeutics Corporation | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.